Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Lung Cancer (Amsterdam, Netherlands)
|
July 21, 2020
The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer
J M Varlotto, R Voland, M M DeCamp, et al.
AJNR. American Journal of Neuroradiology
|
October 11, 2014
Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study)
K R Maravilla, M P Smith, J Vymazal, et al.
AJNR. American Journal of Neuroradiology
|
July 18, 2015
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)
M Vaneckova, M Herman, M P Smith, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Lung Cancer (Amsterdam, Netherlands)
|
July 21, 2020
The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer
J M Varlotto, R Voland, M M DeCamp, et al.
AJNR. American Journal of Neuroradiology
|
October 11, 2014
Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study)
K R Maravilla, M P Smith, J Vymazal, et al.
AJNR. American Journal of Neuroradiology
|
July 18, 2015
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)
M Vaneckova, M Herman, M P Smith, et al.
Page
of 2